Arrowhead Pharmaceuticals Inc. buy Sumitomo Mitsui Financial Group, Inc.
Start price
26.04.23
/
50%
€30.42
Target price
26.04.24
€72.10
Performance (%)
-32.54%
End price
27.04.24
€20.52
Summary
This prediction ended on 27.04.24 with a price of €20.52. Massive losses of -32.54% were the result for the BUY prediction by Sumitomo_Mitsui_Fina. Sumitomo_Mitsui_Fina has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 7.386% | 7.386% | 307.410% |
| iShares Core DAX® | -1,74 % | -10,68 % | -0,89 % |
| iShares Nasdaq 100 | -2,58 % | -3,32 % | 11,12 % |
| iShares Nikkei 225® | -1,16 % | -9,36 % | 23,69 % |
| iShares S&P 500 | -1,42 % | -3,76 % | 7,19 % |
Comments by Sumitomo_Mitsui_Fina for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is now covered by analysts at Sumitomo Mitsui Financial Group, Inc.. They set an "outperform" rating and a $80.00 price target on the stock.
Ratings data for ARWR provided by MarketBeat
In the thread Trading Arrowhead Pharmaceuticals Inc.
Die von Sumitomo_Mitsui_Fina gewählte maximale Laufzeit wurde überschritten